News | Orthopedic Imaging | January 11, 2018

A new study indicates that those who receive steroid injections in the hip have higher incidence of bone death and collapse 

Hip Steroid Injections Associated with Bone Changes

58-year-old woman with left hip pain. X-ray from one month prior to the steroid/anesthetic injection demonstrates moderate joint space narrowing (arrows) and bony proliferation (arrowheads).


January 11, 2018 – Osteoarthritis patients who received a steroid injection in the hip had a significantly greater incidence of bone death and collapse compared with control groups, according to new research presented at the annual meeting of the Radiological Society of North America (RSNA), Nov. 26-Dec. 1 in Chicago.

Receiving an injection of a steroid and anesthetic is a common treatment for patients who are experiencing pain and inflammation in a joint, such as the hip, knee or shoulder.

"Changes due to osteoarthritis, such as narrowing in the space between joints and the development of bony proliferations, typically develop slowly over time," said Connie Y. Chang, M.D., radiologist at Massachusetts General Hospital and assistant professor of radiology at Harvard Medical School in Boston. "When reading follow-up radiographs of patients who had received a hip injection, we noticed changes had developed rapidly in some patients."

To determine whether arthritis worsened in patients following a hip steroid/anesthetic injection, Chang and a team of radiologists specializing in musculoskeletal diagnostic imaging and intervention, including hip injections, conducted a study involving 102 patients (age range 19-92, including 62 women) who received X-ray images of the treated hip at the time of the injection and during a follow-up three to nine months later.

Two musculoskeletal radiologists independently reviewed the X-ray images of the patients who received the injections and those of two control groups matched to demographics and follow-up imaging duration. The control groups consisted of 102 patients who had hip X-rays without steroid/anesthetic injection and 44 patients who underwent imaging and a steroid/anesthetic injection in the shoulder.

The radiologists reported new osteonecrosis in 22-24 percent of hip injection patients, compared to 5-9 percent in the hip control group and 5 percent in the shoulder injection control group. They observed bone collapse in the head of the femur bone, located at the top of the femur at the articulation with the pelvic bone, in 15-17 percent of hip injection patients, versus 4 percent of hip control patients and 2 percent of shoulder control patients.

Hip injection patients also showed increased imaging findings of osteoarthritis compared to the control groups, but the differences were not statistically significant.

Chang noted that patients receiving hip injections have symptoms of hip pain severe enough to require the injection and may be prone to faster progression of bony changes compared to the control groups. These considerations may be important, as some orthopedists are requesting higher steroid doses and injections in younger patients.

"We need to look at what's going on with the steroid/anesthetic injectate and osteoarthritis patients to determine what's causing the changes that occur in some patients," Chang said. "However, we don't want to deter patients from getting an injection. These results are enough to warrant an investigation, but not enough to cancel a procedure."

Co-authors are F. Joseph Simeone, M.D., Joao Rafael T. Vicentini, M.D., and Susan V. Kattapuram, M.D.

For more information: www.rsna.org  

Related Content

Key RSNA 2017 Study Presentations, Trends and Video

Related Content

News | Contrast Media

May 19 2022 — Recent disruptions in a pharmaceutical supply chain have impacted the global availability of GE Healthcare ...

Time May 19, 2022
arrow
Feature | Coronavirus (COVID-19)

Clinical scientists used machine learning (ML) models to explore de-identified electronic health record (EHR) data in ...

Time May 18, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

May 13, 2022 — Alzheimer’s disease is the most common form of dementia, one of the major causes of dependency and ...

Time May 13, 2022
arrow
News | Radiology Business

May 12, 2022 — Abbott announced a new partnership with Women as One to launch a new program designed to train more ...

Time May 12, 2022
arrow
News | Radiology Imaging

May 5, 2022 — Significant imaging findings (cancer, infection, pseudoaneurysm, fracture, bowel perforation) can occur in ...

Time May 05, 2022
arrow
News | Radiation Therapy

May 4, 2022 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy (BgRT) ...

Time May 04, 2022
arrow
Feature | Digital Radiography (DR) | By Melinda Taschetta-Millane

The COVID-19 pandemic turned the spotlight on diagnostic imaging by demanding a need for high-speed workflow and ...

Time May 03, 2022
arrow
News | Digital Radiography (DR)

April 28, 2022 — Boston Imaging, the United States headquarters of Samsung digital radiography and ultrasound systems ...

Time April 28, 2022
arrow
News | Radiation Therapy

April 26, 2022 — A group of CNIO researchers headed by Manuel Valiente have found a new strategy that could be used in ...

Time April 26, 2022
arrow
News | Artificial Intelligence

April 26, 2022 — The companies conducted a joint pilot study, where Oxipit’s ChestEye Quality AI software is employed ...

Time April 26, 2022
arrow
Subscribe Now